Alzamend Neuro, Inc. (ALZN) Stock Price, News, Quote & History - Yahoo Finance

By Yahoo! Finance | Aug 19, 2024 at 11:40 AM EST

Alzamend Neuro focuses on developing treatments for neurodegenerative and psychiatric disorders, including Alzheimer's and bipolar disorder. Their pipeline includes AL001 and ALZN002, with a partnership with Massachusetts General Hospital for clinical trials.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.